METHOD OF TREATING DYSTROPHIC DISEASES OF VULVA Russian patent published in 2013 - IPC A61N5/67 A61K31/409 A61P15/00 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, namely to gynaecology, and may be used for treating dystrophic diseases of the vulva by photodynamic therapy. That is ensured by intravenous administration of Photoditazine 0.8-1.0 mg/kg, and 90-120 minutes later, it is followed by the unanesthetised light exposure on the area of the vulva in a continuous mode by a LED apparatus at wave length 660 nm. A dose of the supplied light energy is 180-250 J/cm² for a total length of light exposure of 30-50 minutes. If the clinical symptoms of the disease appear to be persistent, the photodynamic therapy is repeated to achieve a positive therapeutic effect. With a large area of abnormality, the vulva area is divided into quadrants that are consistently exposed to light.

EFFECT: method provides a highly effective minimally invasive, organ preservation method of treating dystrophic diseases of the vulva, which provides a complete recovery of the disease; it is not accompanied by side effects, enables reducing the length of treatment, ensuring the treatment in an outpatient setting.

3 cl, 3 ex